不同程度肥胖儿童血清25羟维生素D、人去乙酰化酶4水平与糖脂代谢关系分析

来源 :中国基层医药 | 被引量 : 0次 | 上传用户:dx0746
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探究不同程度肥胖儿童血清25羟维生素D[25(OH)D]、人去乙酰化酶4(SIRT4)水平与糖脂代谢的关系。方法:选取2016年2月至2021年2月绍兴市妇女儿童保健院收治的肥胖儿童124例为研究对象,参照体质量指数(BMI)分为轻/中度肥胖组(76例)以及重度肥胖组(48例),并选取同期在该院体检健康儿童62例为对照组。收集各组儿童一般资料,分析儿童肥胖影响因素及血清25(OH)D、SIRT4水平与糖脂代谢的关系。结果:三组儿童体质量[(26.68±4.98)kg、(33.24±5.48)kg、(37.18±5.88)kg]、腰围[(56.12±4.62)cm、(68.45±5.20)cm、(79.34±5.65)cm]、臀围[(68.42±5.08)cm、(72.45±6.45)cm、(80.56±6.95)cm]、BMI[(15.90±2.04)kg/mn 2、(23.58±2.45)kg/mn 2、(25.89±2.35)kg/mn 2]、胰岛素(FINS)[(26.65±3.68)pmol/L、(34.82±4.15)pmol/L、(48.56±5.49)pmol/L]、胰岛素抵抗指数(HOMA-IR)[(1.06±0.24)、(2.12±0.35)、(3.84±0.52)]、总胆固醇(TC)[(2.21±0.45)mmol/L、(4.14±0.58)mmol/L、(5.96±0.64)mmol/L]、三酰甘油(TG)[(0.68±0.16)mmol/L、(1.12±0.24)mmol/L、(1.56±0.35)mmol/L]、低密度脂蛋白胆固醇(LDL-C)[(2.68±0.42)mmol/L、(2.10±0.32)mmol/L、(1.41±0.25)mmol/L]、高密度脂蛋白胆固醇(HDL-C)[(1.98±0.42)mmol/L、(3.12±0.51)mmol/L、(4.10±0.56)mmol/L]差异均有统计学意义(n F=53.62、280.42、53.33、303.44、338.48、755.71、618.75、165.81、186.89、251.42,均n P < 0.001);各组体质量、腰围、臀围、BMI、FINS、HOMA-IR、TC、TG、HDL、LDL两两比较:对照组 < 轻/中度组( n t=-7.28、-14.56、-4.00、-19.72、-6.49、-21.45、-12.36、9.20、-14.12,均n P < 0.05)、轻/中度组 < 重度组( n t=-3.79、-10.98、-6.61、-5.19、-15.81、-22.02、-16.34、-8.30、12.68、-10.03,均n P 轻/中度组[(60.52±8.95)nmol/L比(49.88±8.12)nmol/L]、[(1.98±0.38)mmol/L比(1.06±0.30)mmol/L]( n t=7.31、15.89,均n P 重度组[(49.88±8.12)nmol/L比(41.62±7.50)nmol/L]、[(1.06±0.30)mmol/L比(0.52±0.15)mmol/L]( n t=5.68、11.57,均n P < 0.05)。多元线性回归分析显示,体质量、腰围、臀围、FINS、HOMA-IR、TC、TG、LDL是儿童肥胖的正向影响因素(n B=0.170、0.310、0.403、1.000、3.464、2.080、2.656、4.324);HDL、血清25(OH)D及SIRT4是儿童肥胖的负向影响因素(n B=-2.096、-0.156、-6.615)。Pearson相关性分析显示,血清25(OH)D与FINS、HOMA-IR、TC、TG、LDL均呈显著负相关(n r=-0.20、-0.46、-0.30、-0.36,均n P < 0.01),与FPG、HDL呈显著正相关( n r=0.43、0.77,均n P < 0.01);血清SIRT4与FINS、TC、TG、LDL均呈显著负相关( n r=-0.48、-0.74、-0.61、-0.64,均n P < 0.01),与FPG、HDL呈显著正相关( n r=0.21、0.84,均n P < 0.01)。n 结论:血清25(OH)D、SIRT4水平随儿童肥胖程度的加重而降低,且与糖脂代谢关系密切,因此早期检测可反映儿童肥胖程度及糖脂代谢情况。“,”Objective:To investigate the relationship between serum 25(OH)D and SIRT4 levels and glycolipid metabolism in children with different levels of obesity.Methods:A total of 124 children with different levels of obesity who received treatment in Shaoxing Women\'s and Children\'s Health Care Hospital from February 2016 to February 2021 were included in this study. These children were divided into mild/moderate obesity group (n n = 76) and severe obesity group (n n = 48) according to body mass index. An additional 62 healthy children who concurrently received a physical examination were selected for controls. The general data of all children were collected. The relationship between the factors that affect obesity in children and serum 25(OH)D and SIRT4 levels and glycolipid metabolism was analyzed.n Results:In the control, mild/moderate obesity, and severe obesity groups, body mass was (26.68 ± 4.98) kg, (33.24 ± 5.48) kg, (37.18 ± 5.88) kg, respectively; waist circumference was (56.12 ± 4.62) cm, (68.45 ± 5.20) cm, (79.34 ± 5.65) cm, respectively; hip circumference was (68.42 ± 5.08) cm, (72.45 ± 6.45) cm, (80.56 ± 6.95) cm, respectively; body mass index (BMI) was (15.90 ± 2.04) kg/mn 2, (23.58 ± 2.45) kg/mn 2, (25.89 ± 2.35) kg/mn 2], respectively; fasting insulin (FINS) level was (26.65 ± 3.68) pmol/L, (34.82 ± 4.15) pmol/L, (48.56 ± 5.49) pmol/l, respectively; homeostasis model assessment of insulin resistance (HOMA-IR) was (1.06 ± 0.24), (2.12 ± 0.35), (3.84 ± 0.52), respectively; total cholesterol (TC) level was (2.21 ± 0.45) mmol/L, (4.14 ± 0.58) mmol/L, (5.96 ± 0.64) mmol/L, respectively; triacylglycerol (TG) level was (0.68 ± 0.16) mmol/L, (1.12 ± 0.24) mmol/L, (1.56 ± 0.35) mmol/L, respectively; low density lipoprotein cholesterol (LDL-C) was (2.68 ± 0.42) mmol/L, (2.10 ± 0.32) mmol/L, (1.41 ± 0.25) mmol/L, respectively; high density lipoprotein cholesterol (HDL-C) was (1.98 ± 0.42) mmol/L, (3.12 ± 0.51) mmol/L, (4.10 ± 0.56) mmol/L, respectively. There were significant differences in body mass, waist circumference, hip circumference, BMI, FINS, HOMA-IR, TC, TG, HDL-C, and LDL-C among the three groups (n F = 53.62, 280.42, 53.33, 303.44, 338.48, 755.71, 618.75, 165.81, 186.89, 251.42, all n P < 0.001). Body mass, waist circumference, hip circumference, BMI, FINS, HOMA-IR, TC level, TG level, HDL-C level, and LDL-C level were lower in the control group than in the mild/moderate obesity group ( n t = -7.28, -14.56, -4.00, -19.72, -6.49, -21.45, -12.36, 9.20, -14.12, all n P < 0.05). Body mass, waist circumference, hip circumference, BMI, FINS, HOMA-IR, TC, TG, HDL-C and LDL-C were lower in the mild/moderate obesity group than in the severe obesity group ( n t = -3.79, -10.98, -6.61, -5.19, -15.81, -22.02, -16.34, -8.30, 12.68, -10.03, all n P < 0.05). Serum 25(OH)D [(60.52 ± 8.95) nmol/L n vs. (49.88 ± 8.12) nmol /L, n t = 7.31, n P < 0.05] and SIRT4 [(1.98 ± 0.38) mmol/L n vs. (1.06 ± 0.30) mmol/L,n t = 15.89, n P < 0.05] levels were significantly greater in the control group than in the mild/moderate obesity group. Serum 25(OH)D [(49.88 ± 8.12) nmol/L n vs. (41.62 ± 7.50) nmol /L, n t = 5.68, n P < 0.05] and SIRT4 [(1.06 ± 0.30) mmol/L n vs. (0.52 ± 0.15) mmol/L, n t = 11.57, n P < 0.05] levels were significantly greater in the mild/moderate obesity group than in the severe obesity group. Multiple linear regression analysis showed that body mass, waist circumference, hip circumference, FINS, HOMA-IR, TC, TG, and LDL were the positive influential factors of childhood obesity ( n B = 0.170, 0.310, 0.403, 1.000, 3.464, 2.080, 2.656, 4.324); HDL, serum 25(OH)D and SIRT4 were the negative influential factors of childhood obesity (n B = -2.096, -0.156, -6.615). Pearson correlation analysis showed that serum 25(OH)D was significantly negatively correlated with FINS, HOMA-IR, TC, TG and LDL (n r = -0.20, -0.46, -0.30, -0.36, all n P < 0.01), and significantly positively correlated with FPG and HDL ( n r = 0.43, 0.77, both n P < 0.01). Serum SIRT4 was negatively correlated with FINS, TC, TG, and LDL ( n r = -0.48, -0.74, -0.61, -0.64, all n P < 0.01), and positively correlated with FPG and HDL ( n r = 0.21, 0.84, both n P < 0.01).n Conclusion:Serum 25(OH)D and SIRT4 levels decrease with the aggravation of obesity in children and are closely related to glycolipid metabolism. Therefore, early detection of obesity can reflect the degree of obesity and glycolipid metabolism in children.
其他文献
目前,我国心血管病患病率仍处于上升阶段.心血管病现患人数约3.3亿,其中冠心病患者约1139万人[1].2019年《欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南》[2]根据临床表现将冠心病分为急性冠状动脉综合征(acute coronary syndromes, ACS)和慢性冠状动脉综合征(chronic coronary syndromes,CCS),对不同临床类型的CCS提出了诊治和管理新理念,并将增强型体外反搏(enhanced external counter-pulsation,EECP)纳
目的:探讨超声引导下经皮穿刺不同方案硬化治疗单纯性肾囊肿的临床疗效。方法:选取2017年1月至2020年1月长兴县人民医院泌尿外科收治的120例单纯性肾囊肿患者为研究对象,患者均进行超声引导下经皮穿刺治疗。按照随机数字表法分为保留法治疗组、冲洗置换法治疗组、聚桂醇治疗组,每组患者40例,分别给予医用无水乙醇灌注保留法治疗、医用无水乙醇冲洗置换法治疗和聚桂醇保留法治疗。比较三组患者的一般资料、手术进行情况、并发症发生率、手术疗效等评价指标。结果:三组患者的性别、年龄、病程、囊肿大小、囊肿分布位置等基础资料差
目的:探讨多西他赛联合顺铂二线治疗老年人晚期非小细胞肺癌的有效性和安全性。方法:选取胶州市人民医院2017年1月至2019年12月收治的需行二线治疗的老年人晚期非小细胞肺癌120例为观察对象。采用随机数字表法分为观察组和对照组,每组60例。对照组患者接受多西他赛治疗,观察组患者接受多西他赛联合顺铂治疗。比较两组临床疗效及并发症发生情况。结果:化疗后,观察组化疗近期总有效率[70.00%(42/60)]高于对照组[33.33%(20/60)],差异有统计学意义(χn 2=16.15,n
尽管他汀类药物能显著降低低密度脂蛋白胆固醇浓度,从而显著减少心血管事件,但冠状动脉粥样硬化性心脏病(冠心病)患者仍存在其他重要的残余心血管风险,例如炎症[1].炎症在冠心病的发生、发展和表现中起着关键作用,因此医学界一直在艰辛探索将抗炎治疗在临床上应用于动脉粥样硬化性患者[2-3].过去几年,以分别应用卡那单抗、甲氨蝶呤和秋水仙碱的随机双盲安慰剂对照临床试验为代表的研究表明,为预防和治疗动脉粥样硬化临床并发症,靶向抗炎治疗提供了一种有希望的新途径.卡那单抗是单克隆抗体制剂,价格高,并且相关研究较少,目前难
目的 探讨改良性BridgePoint系统即Corsair微导管替代CrossBoss导管辅助Stingray球囊的正向夹层再进入技术开通冠状动脉慢性完全闭塞(CTO)病变的安全性及有效性.方法 对2016年6月至2019年9月空军军医大学第一附属医院连续应用Corsair微导管替代CrossBoss导管辅助Stingray球囊的正向夹层再进入技术尝试开通45例CTO病变患者的安全性、有效性进行分析.结果 45例患者中男性41例(91.1%),平均年龄(58.5±12.6)岁,日本多中心CTO注册研究评分
目的:探讨过表达长链非编码RNA(lncRNA)FAM224B对大鼠重症肺炎肺组织的保护作用及机制。方法:研究时间为2020年8月至2021年3月,将20只大鼠采用随机数字表法分为肺炎组(重症肺炎模型)和FAM224B组(重症肺炎模型+FAM224B质粒),每组10只。实时定量聚合酶链式反应(qRT-PCR)测定肺组织FAM224B水平,酶联免疫吸附测定法(ELISA)检测肺组织匀浆中肿瘤坏死因子α(TNF-α)、白细胞介素(IL)6、IL-1β水平,生物信息学软件starBase v2预测FAM224B
目的:评价超微血管成像技术用于诊断颈动脉斑块新生血管情况及稳定性的临床价值。方法:选取2018年6月至2020年6月于温州市第七人民医院就诊的72例颈动脉粥样硬化斑块患者为研究对象,并经手术取出颈动脉斑块100处,于颈动脉斑块取出术前分别进行超微血管成像和超声造影检查,并以斑块病理检查结果为金标准,评估不同检查方法对劲动脉斑块新生血管和稳定性的诊断效能,统计不同检查方法诊断结果与金标准的一致性。结果:超微血管成像检查对于颈动脉斑块新生血管情况的诊断灵敏度、特异度和准确度分别为93.24%、92.31%和9
目的:探讨体素内不相干运动扩散加权成像(IVIM-DWI)联合血清指标对前列腺癌的鉴别诊断价值。方法:选取诸暨市人民医院2018年3月至2020年9月收治的前列腺疾病患者97例为研究对象,其中前列腺癌患者(46例)为研究组,前列腺增生患者(51例)为对照组,分别对其行IVIM-DWI诊断、血清前列腺癌抗原2(EPCA-2)检测以及联合检测,比较两组患者IVIM-DWI诊断、血清EPCA-2检测以及联合检测的敏感度、特异度、准确度及其诊断效能。结果:研究组D值[(0.50±0.14)×10n -3
目的:观察超声心动图技术用于诊断胎儿心律失常的临床价值。方法:选取2018年3月至2020年3月于温州医科大学附属苍南医院定期进行产前检查的1 500例妊娠期女性为研究对象,研究对象均于妊娠中期(24~26周)进行胎儿超声心动图检测,评估研究对象中胎儿心律失常及合并胎儿结构异常发生情况,统计胎儿心律失常及合并胎儿结构异常检出率,比较正常胎儿与心律失常胎儿在降主动脉、脐动脉和大脑中动脉管径差异情况。结果:在全部1 500例妊娠期女性中,妊娠中期,通过超声心动图检测共筛查出心律失常病例131例,胎儿心律失常发
肺高血压是一类进展性、恶化性心血管疾病,其真正的发病机制尚未阐明.回顾2021年,肺高血压领域涌现出大量精彩的临床和基础研究,为我们探讨肺高血压的发病机制、寻求新的治疗方式提供了重要参考,也为该类患者群体带来了新希望.本文逐一盘点2021年度肺高血压领域研究的重大进展,为2022年开展工作提供重要参考资料.